Navigating 340B: Operational Strategies to Manage Regulatory Change
April 6, 2026Join experienced professionals from Forvis Mazars and Denise Scarpelli, vice president and chief pharmacy officer at UChicago Medicine, for an in-depth discussion of the latest legislative and regulatory developments affecting the 340B Drug Pricing Program. This webinar is designed to provide insight into the implications for essential hospitals, implementation of the 340B Rebate Model Pilot Program from the Health Resources and Services Administration (HRSA), ongoing litigation, and potential legislation. The presenters will also share operational strategies essential hospitals can use to help navigate these evolving requirements while continuing to fulfill their mission of providing access to affordable care in underserved communities.
Learning Objectives
Upon completion of this program, participants will be able to:
- Discuss how recent legislative and regulatory changes to 340B may affect healthcare organizations.
- Identify current and emerging challenges and opportunities related to 340B.
- Apply operational strategies to help comply with evolving 340B requirements.
Presenter(s)
Brian Bell, Chad Mulvany, Denise Scarpelli, PharmD, MBA, UChicago Medicine